Business ❯ Finance ❯ Investments ❯ Mergers and Acquisitions

Pharmaceutical Acquisitions

Eli Lilly Agrees to Buy Psychedelic Biotech AtaiBeckley for $2.8 Billion

The purchase gives Lilly late-stage exposure to psychedelic therapies, with most additional value tied to clinical, regulatory, rescheduling milestones.

14 ARTICLES

2mo ago

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

10 ARTICLES

8mo ago

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

9 ARTICLES

8mo ago

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion in Bet on Oral NLRP3 Drugs

11 ARTICLES

9mo ago

Sanofi to Buy Dynavax for $2.2 Billion in All-Cash Tender Offer

12 ARTICLES

9mo ago

Samsung Biologics to Buy GSK’s Human Genome Sciences Campus for $280 Million

6 ARTICLES

11mo ago

Lilly to Buy Adverum in Gene‑Therapy Deal Worth Up to $12.47 a Share

27 ARTICLES

last yr.

Pfizer to Buy Metsera for $4.9 Billion Upfront in Return to Obesity Drugs

10 ARTICLES

last yr.

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

9 ARTICLES

last yr.

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Pharmaceutical Acquisitions

Eli Lilly Agrees to Buy Psychedelic Biotech AtaiBeckley for $2.8 Billion

Vertex to Buy Crinetics for $10 Billion, Gaining Oral Endocrine Drugs

AbbVie to Buy Apogee for About $10.9 Billion to Add Clinical-Stage IL-13 Drug

AbbVie Agrees to Buy Apogee Therapeutics for $10.9 Billion

GSK to Buy Nuvalent for $10.6 Billion to Bolster Lung‑Cancer Pipeline

Lilly Agrees to Buy Three Vaccine Developers for Up to $3.8 Billion

Sun Pharma to Buy Organon for $11.75 Billion in All-Cash Deal

Gilead to Acquire Tubulis for Up to $5 Billion to Boost Cancer ADC Pipeline

Novartis to Acquire Excellergy in Up to $2 Billion Deal for Next-Gen Anti-IgE

Merck to Acquire Terns for $6.7 Billion to Add Promising Leukemia Drug

Never miss stories about

Pharmaceutical Acquisitions

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion in Bet on Oral NLRP3 Drugs

Sanofi to Buy Dynavax for $2.2 Billion in All-Cash Tender Offer

Samsung Biologics to Buy GSK’s Human Genome Sciences Campus for $280 Million

Lilly to Buy Adverum in Gene‑Therapy Deal Worth Up to $12.47 a Share

Pfizer to Buy Metsera for $4.9 Billion Upfront in Return to Obesity Drugs

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

Sanofi to Acquire Blueprint Medicines for $9.1 Billion, Boosting Its Rare Immunology Pipeline

Never miss stories about

Pharmaceutical Acquisitions